Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.1K Buy
+540
New +$24.5K ﹤0.01% 1037
2022
Q1
– Sell
-33,700
Closed -$1.53M – 1180
2021
Q4
$1.53M Sell
33,700
-183,100
-84% -$9.6M 0.01% 839
2021
Q3
$13.7M Buy
216,800
+89,800
+71% +$6.84M 0.05% 300
2021
Q2
$11.6M Buy
+127,000
New +$10.1M 0.05% 259

Other funds holding CDNA

Natixis's CDNA Position: Q3 2026 in Review

Natixis opened a new position in CareDx (CDNA) in Q3 2026: 540 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #1037 among its holdings. This is a return to the name: Natixis previously reported a position in CDNA as recently as Q4 2021.

Natixis first reported a position in CDNA in Q2 2021 and has held it in 4 quarters since. The position peaked at $13.7M in Q3 2021. 140 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Natixis held 540 shares of CareDx worth $35.1K as of Q3 2026.
  • CareDx was a new Natixis position in Q3 2026.
  • CareDx made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #1037 holding.
  • Natixis first reported a position in CareDx in Q2 2021 and has held it in 4 quarters since.
  • Natixis's CareDx position peaked at $13.7M in Q3 2021.
  • 140 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.